STIGALL L. JEREMY 4

What Happened

• Jeremy Stigall, Chief Business Officer of ClearPoint Neuro (CLPT), had 8,291 restricted stock units (RSUs) settle into common shares on March 11, 2026. Of those shares, 3,224 were delivered back to the company to satisfy tax withholding at $11.62 per share, totaling $37,463, leaving a net 5,067 shares issued to him.
• This was a scheduled vesting/settlement of RSUs (insider code M for conversion/exercise and code F for tax withholding). This is an award/vesting event rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-11; Form filed: 2026-03-13 (no late filing indicated).
• RSUs settled: 8,291 shares; shares withheld for taxes: 3,224 at $11.62/share = $37,463.
• Net shares received by insider: 5,067 shares.
• Footnotes: F1 confirms these were RSUs settled on their scheduled vesting date; F2 confirms the 3,224 shares were delivered to CLPT to satisfy tax withholding.
• Shares owned after transaction: not specified in the provided filing excerpt.

Context

• This was a routine vesting/settlement of previously granted RSUs; the tax withholding (share surrender) is a common cashless method to cover required taxes and does not by itself indicate buy/sell sentiment.
• Transaction codes: M denotes conversion/exercise of a derivative (here, RSUs converting into common stock); F denotes shares delivered to satisfy tax liabilities.